Literature DB >> 9916057

The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

B Picard1, J S Garcia, S Gouriou, P Duriez, N Brahimi, E Bingen, J Elion, E Denamur.   

Abstract

Previous studies suggesting a link between Escherichia coli phylogenetic groups and extraintestinal virulence have been hampered by the difficulty in establishing the intrinsic virulence of a bacterial strain. Indeed, unidentified virulence factors do exist, and the susceptibility of the host to infection is highly variable. To overcome these difficulties, we have developed a mouse model of extraintestinal virulence to test the virulence of the strains under normalized conditions. We then assessed the phylogenetic relationships compared to the E. coli reference (ECOR) collection, the presence of several known virulence determinants, and the lethality to mice of 82 human adult E. coli strains isolated from normal feces and during the course of extraintestinal infections. Commensal strains belong mainly to phylogenetic groups A and B1, are devoid of virulence determinants, and do not kill the mice. Strains exhibiting the same characteristics as the commensal strains can be isolated under pathogenic conditions, thus indicating the role of host-dependent factors, such as susceptibility linked to underlying disease, in the development of infection. Some strains of phylogenetic groups A, B1, and D are able to kill the mice, their virulence being most often correlated with the presence of virulence determinants. Lastly, strains of the B2 phylogenetic group represent a divergent lineage of highly virulent strains which kill the mice at high frequency and possess the highest level of virulence determinants. The observed link between virulence and phylogeny could correspond to the necessity of virulence determinants in a genetic background that is adequate for the emergence of a virulent clone, an expression of the interdependency of pathogenicity and metabolic activities in pathogenic bacteria.

Entities:  

Mesh:

Year:  1999        PMID: 9916057      PMCID: PMC96353     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Characterization of highly virulent Escherichia coli strains by ribosomal DNA restriction fragment length polymorphism.

Authors:  B Picard; N Picard-Pasquier; R Krishnamoorthy; P Goullet
Journal:  FEMS Microbiol Lett       Date:  1991-08-01       Impact factor: 2.742

2.  Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis.

Authors:  J R Johnson; P Goullet; B Picard; S L Moseley; P L Roberts; W E Stamm
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli.

Authors:  P J Herzer; S Inouye; M Inouye; T S Whittam
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

4.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Analysis of the variability of S-fimbriae expression in an Escherichia coli pathogen.

Authors:  M Ott; J Hacker
Journal:  FEMS Microbiol Lett       Date:  1991-04-15       Impact factor: 2.742

6.  Clonal relationships among Escherichia coli serogroup 06 isolates from human and animal infections.

Authors:  A Cherifi; M Contrepois; B Picard; P Goullet; I Orskov; F Orskov; J De Rycke
Journal:  FEMS Microbiol Lett       Date:  1991-05-15       Impact factor: 2.742

7.  Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli.

Authors:  K Tullus; A Brauner; B Fryklund; T Munkhammar; W Rabsch; R Reissbrodt; L G Burman
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

8.  Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.

Authors:  C Le Bouguenec; M Archambaud; A Labigne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

9.  Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection.

Authors:  E Bingen; E Denamur; N Lambert-Zechovsky; Y Aujard; N Brahimi; P Geslin; J Elion
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

10.  Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons.

Authors:  M Arthur; R D Arbeit; C Kim; P Beltran; H Crowe; S Steinbach; C Campanelli; R A Wilson; R K Selander; R Goldstein
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

View more
  277 in total

1.  Improved repetitive-element PCR fingerprinting of Salmonella enterica with the use of extremely elevated annealing temperatures.

Authors:  J R Johnson; C Clabots
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Clonal origin, virulence factors, and virulence.

Authors:  J R Johnson; M Kuskowski
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 3.  Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  M S Donnenberg; T S Whittam
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Automated ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains.

Authors:  O Clermont; C Cordevant; S Bonacorsi; A Marecat; M Lange; E Bingen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

6.  An Escherichia coli reference collection group B2- and uropathogen-associated polymorphism in the rpoS-mutS region of the E. coli chromosome.

Authors:  D E Culham; J M Wood
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

7.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

8.  Wild coastline birds as reservoirs of broad-spectrum-β-lactamase-producing Enterobacteriaceae in Miami Beach, Florida.

Authors:  Laurent Poirel; Anaïs Potron; Carolina De La Cuesta; Timothy Cleary; Patrice Nordmann; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

9.  Structural insights into the biogenesis and biofilm formation by the Escherichia coli common pilus.

Authors:  James A Garnett; Verónica I Martínez-Santos; Zeus Saldaña; Tillmann Pape; William Hawthorne; Jennifer Chan; Peter J Simpson; Ernesto Cota; José L Puente; Jorge A Girón; Steve Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

10.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.